Bvf Inc Molecular Partners Ag Put Options Transaction History
Bvf Inc
- $2.54 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MOLN
# of Institutions
7Shares Held
3.59MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$8.33 Million0.29% of portfolio
-
Ubs Group Ag10.2KShares$38,2460.0% of portfolio
-
Morgan Stanley New York, NY367Shares$1,3760.0% of portfolio
-
Bank Of America Corp Charlotte, NC157Shares$5880.0% of portfolio
-
Ever Source Wealth Advisors, LLC41Shares$1530.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $122M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...